Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-22-062916

Chairman & CEO bought 37,500 shares at $0.64 ($24,124)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHADE CHRISTIAN S Chairman & CEO 2022-05-18 Purchase +37,500 $0.64 $24,124 292,616 D
Open-market purchases · 37,500 sh · avg $0.64 · $24,124
Loading xslF345X03/tm2216022-1_4seq1.xml…